<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83268">
  <stage>Registered</stage>
  <submitdate>14/10/2008</submitdate>
  <approvaldate>22/09/2009</approvaldate>
  <actrnumber>ACTRN12609000826246</actrnumber>
  <trial_identification>
    <studytitle>Light restriction in retinal degeneration</studytitle>
    <scientifictitle>Light restriction in retinal degeneration and potential to slow visual loss</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Retinal degenerations in particular retinitis pigmentosa</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>1 They will be asked to wear an occluding lens (This is an eye patch that fits over the wearers glasses or sticks to the skin if the participant doesn't wear glasses these are the same as what children who have amblyopia "lazy eye" wear) on one eye for up to 12 weeks.
1a. The patch is worn full time during waking hours. There are two exceptions firstly for bathing/ showering and secondly for driving a car. The total time the patch is off should be less than 1 hour.</interventions>
    <comparator>The other eye will provide an internal control</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>An improvement in Electrophysiology parameters. The parameters measured are: Dark Rod, Maximum rod, Single flash cone, 30Hz flicker and Fused flicker parameters on the Electroretinogram and Dark Adaptation</outcome>
      <timepoint>They will be tested on three occasions before beginning the trial, and at 1w, 2w, 4w, 8w and 12 w after beginning the wearing of the occluder.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Full threshold Visual field will be measure using the Humphrey automated perimeter on a 24-2 test</outcome>
      <timepoint>They will be tested on three occasions before beginning the trial, and at 1w, 2w, 4w, 8w and 12 w after beginning the wearing of the occluder.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1.Subjects will have  a diagnosis of retinal degeneration, with the following admission criteria:
Rod-cone dystrophy, non-syndromic
Age 18-35
Flash Electroretinogram (ERG) still detectable
Dark-adapted thresholds at least 20% of normal</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Free of significant other ophthalmic pathology (eg cataract macular oedema or glaucoma)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence>Non randomised</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>Uncovered eye will be internal control</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/11/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr John Grigg</primarysponsorname>
    <primarysponsoraddress>Save Sight Institute
Sydney University
Sydney Eye Hospital Campus
Macquarie Street
Sydney NSW 2001</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Save Sight Institute, Sydney University</fundingname>
      <fundingaddress>Sydney Eye Hospital Campus
Macquarie Street
Sydney NSW 2001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Prof Jonathan Stone</sponsorname>
      <sponsoraddress>Save Sight Institute
Sydney University
Sydney Eye Hospital Campus
Macquarie Street
Sydney NSW 2001</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Studies in animals with retinal dystrophies shows benefit from light restriciton. In particular improvement in retinal function as measured by an elecroretinogram. This study is being undertaken to see if restricting light exposure in people with retinal dystrophies improves retinal function.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney University</ethicname>
      <ethicaddress>Camperdown 
Sydney NSW 2006</ethicaddress>
      <ethicapprovaldate>1/08/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof Jonathan Stone</name>
      <address>Save Sight Institute
Sydney University
Sydney Eye Hospital Campus
Macquarie Street
Sydney NSW 2001</address>
      <phone>+61 2 93827302</phone>
      <fax>+61 2 93827372</fax>
      <email>Jonathan Stone [jonathan.stone@anu.edu.au]</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr John Grigg</name>
      <address>Save Sight Institute
Sydney University
Sydney Eye Hospital Campus
Macquarie Street
Sydney NSW 2001</address>
      <phone>+61 2 93827302</phone>
      <fax>+61 2 93827372</fax>
      <email>johng@eye.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr John Grigg</name>
      <address>Save Sight Institute
Sydney University
Sydney Eye Hospital Campus
Macquarie Street
Sydney NSW 2001</address>
      <phone>+61 2 93827302</phone>
      <fax>+61 2 93827372</fax>
      <email>johng@eye.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>